Ken Griffin Night Hawk Biosciences, Inc. Transaction History

Citadel Advisors LLC

  • $483 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$0.26 - $0.51 $4,059 - $7,962
15,612 Added 508.7%
18,681 $8,000
Q3 2023

Nov 14, 2023
BUY
$0.5 - $0.72 $1,534 - $2,209
3,069 New
3,069 $1,000
Q1 2023

May 15, 2023
SELL
$0.83 - $1.24 $26,687 - $39,870
-32,154 Reduced 40.82%
46,620 $40,000
Q4 2022

Feb 14, 2023
BUY
$0.77 - $1.62 $24,030 - $50,556
31,208 Added 65.61%
78,774 $63,000
Q3 2022

Nov 14, 2022
SELL
$1.79 - $2.96 $64,368 - $106,441
-35,960 Reduced 43.05%
47,566 $82,000

Others Institutions Holding NHWK

# of Institutions
5
Shares Held
48.5K
Call Options Held
0
Put Options Held
0
View Full List

About NightHawk Biosciences, Inc.

NHWK Quotes by TradingView
  • Ticker NHWK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,661,500
  • Market Cap $4.11M
  • Description
  • NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...
More about NHWK
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email